Bank of Nova Scotia’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$175M Sell
1,457,238
-498,962
-26% -$57.6M 0.31% 55
2025
Q4
$206M Buy
1,956,200
+579,015
+42% +$54.4M 0.3% 54
2025
Q3
$116M Sell
1,377,185
-53,617
-4% -$4.42M 0.2% 90
2025
Q2
$113M Sell
1,430,802
-1,262,919
-47% -$100M 0.23% 74
2025
Q1
$242M Buy
2,693,721
+734,919
+38% +$68.6M 0.54% 35
2024
Q4
$195M Buy
1,958,802
+744,509
+61% +$76.8M 0.34% 47
2024
Q3
$138M Buy
1,214,293
+408,465
+51% +$48.5M 0.28% 61
2024
Q2
$99.8M Sell
805,828
-107,440
-12% -$13.8M 0.2% 83
2024
Q1
$120M Sell
913,268
-2,231,364
-71% -$275M 0.24% 81
2023
Q4
$343M Buy
3,144,632
+2,449,211
+352% +$254M 0.64% 33
2023
Q3
$71.6M Buy
695,421
+27,759
+4% +$2.99M 0.19% 94
2023
Q2
$77M Buy
667,662
+415,154
+164% +$47.1M 0.2% 86
2023
Q1
$26.9M Sell
252,508
-441,979
-64% -$47.7M 0.08% 175
2022
Q4
$77.1M Sell
694,487
-290,551
-29% -$29.7M 0.2% 91
2022
Q3
$84.8M Sell
985,038
-32,186
-3% -$2.87M 0.27% 67
2022
Q2
$92.7M Sell
1,017,224
-521,090
-34% -$46.2M 0.22% 86
2022
Q1
$126M Sell
1,538,314
-2,566,608
-63% -$202M 0.21% 98
2021
Q4
$315M Buy
4,104,922
+1,842,464
+81% +$147M 0.44% 44
2021
Q3
$170M Buy
2,262,458
+1,270,328
+128% +$96.6M 0.3% 71
2021
Q2
$77.2M Sell
992,130
-1,222,969
-55% -$91M 0.14% 141
2021
Q1
$163M Sell
2,215,099
-1,642,262
-43% -$121M 0.32% 76
2020
Q4
$301M Buy
3,857,361
+1,891,796
+96% +$145M 0.64% 34
2020
Q3
$156M Buy
1,965,565
+999,824
+104% +$78.3M 0.42% 61
2020
Q2
$71.3M Sell
965,741
-1,891,617
-66% -$142M 0.25% 90
2020
Q1
$210M Buy
2,857,358
+177,382
+7% +$13.9M 0.72% 32
2019
Q4
$233M Buy
2,679,976
+523,863
+24% +$43M 0.57% 44
2019
Q3
$173M Buy
2,156,113
+1,427,455
+196% +$114M 0.51% 44
2019
Q2
$56.7M Buy
728,658
+10,744
+1% +$823K 0.24% 92
2019
Q1
$57M Sell
717,914
-34,132
-5% -$2.55M 0.23% 100
2018
Q4
$54.8M Sell
752,046
-774,053
-51% -$54.6M 0.26% 92
2018
Q3
$103M Buy
1,526,099
+922,196
+153% +$58.8M 0.46% 51
2018
Q2
$35M Sell
603,903
-427,528
-41% -$24.1M 0.19% 107
2018
Q1
$53.6M Sell
1,031,431
-189,127
-15% -$10.2M 0.28% 76
2017
Q4
$65.5M Buy
1,220,558
+421,393
+53% +$23.4M 0.3% 71
2017
Q3
$48.8M Sell
799,165
-146,982
-16% -$8.91M 0.28% 82
2017
Q2
$57.9M Sell
946,147
-311,599
-25% -$19M 0.3% 70
2017
Q1
$76.3M Buy
1,257,746
+788,142
+168% +$47.8M 0.33% 59
2016
Q4
$26.4M Buy
469,604
+212,472
+83% +$12.4M 0.14% 106
2016
Q3
$15.3M Buy
257,132
+78,278
+44% +$4.58M 0.09% 121
2016
Q2
$9.83M Sell
178,854
-48,339
-21% -$2.57M 0.06% 157
2016
Q1
$11.5M Buy
227,193
+33,809
+17% +$1.66M 0.07% 136
2015
Q4
$9.75M Buy
193,384
+41,837
+28% +$2.11M 0.05% 185
2015
Q3
$7.15M Sell
151,547
-4,138
-3% -$220K 0.04% 163
2015
Q2
$8.48M Buy
155,685
+17,976
+13% +$1.01M 0.04% 160
2015
Q1
$7.55M Buy
137,709
+974
+0.7% +$55.2K 0.03% 159
2014
Q4
$7.41M Buy
136,735
+3,708
+3% +$207K 0.03% 169
2014
Q3
$7.53M Sell
133,027
-14,326
-10% -$804K 0.03% 163
2014
Q2
$8.13M Sell
147,353
-10,768
-7% -$587K 0.03% 147
2014
Q1
$8.57M Sell
158,121
-18,405
-10% -$953K 0.04% 167
2013
Q4
$8.43M Sell
176,526
-13,105
-7% -$599K 0.04% 177
2013
Q3
$8.62M Sell
189,631
-42,057
-18% -$1.92M 0.04% 133
2013
Q2
$10.3M Buy
+231,688
New +$10.3M 0.05% 133

Other funds holding MRK

Bank of Nova Scotia's MRK Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Merck (MRK) stake by 26% in Q1 2026, selling an estimated $57.6M and leaving 1,457,238 shares worth $175M. The position accounts for 0.31% of the portfolio, ranked #55.

Bank of Nova Scotia first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $343M in Q4 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Bank of Nova Scotia held 1,457,238 shares of Merck worth $175M as of Q1 2026.
  • Bank of Nova Scotia sold 498,962 Merck shares in Q1 2026, an estimated $57.6M.
  • Merck made up 0.31% of Bank of Nova Scotia's portfolio in Q1 2026, its #55 holding.
  • Bank of Nova Scotia first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Bank of Nova Scotia's Merck position peaked at $343M in Q4 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.